{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:32:49Z","timestamp":1793910769612,"version":"4.8.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.canrad.2025.104767","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:06:40Z","timestamp":1763690800000},"page":"104767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Radiotherapy of breast cancer: 2025 update"],"prefix":"10.1016","volume":"29","author":[{"given":"Youssef","family":"Ghannam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8232-6351","authenticated-orcid":false,"given":"Romuald","family":"Le Scodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hennequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bourgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cutuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Richard-Tallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib0530","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"10.1016\/j.canrad.2025.104767_bib0535","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canrad.2021.11.013","article-title":"Radiotherapy of breast cancer","volume":"26","author":"Hennequin","year":"2022","journal-title":"Cancer Radiother"},{"issue":"19","key":"10.1016\/j.canrad.2025.104767_bib0540","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib0545","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9935","key":"10.1016\/j.canrad.2025.104767_bib0550","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.canrad.2025.104767_bib0555","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1200\/JCO.20.00070","article-title":"Accelerated partial breast irradiation and intraoperative partial breast irradiation: reducing the burden of effective breast conservation","volume":"38","author":"White","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104767_bib0560","doi-asserted-by":"crossref","first-page":"m2836","DOI":"10.1136\/bmj.m2836","article-title":"Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial","volume":"370","author":"Vaidya","year":"2020","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.canrad.2025.104767_bib0565","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jamaoncol.2020.0249","article-title":"Effect of delayed targeted intraoperative radiotherapy vs. whole-breast radiotherapy on local recurrence and survival: long-term results from the TARGIT-A randomized clinical trial in early breast cancer","volume":"6","author":"Vaidya","year":"2020","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104767_bib0595","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.ijrobp.2012.03.013","article-title":"Accelerated partial breast irradiation using only intraoperative electron radiation therapy in early stage breast cancer","volume":"84","author":"Maluta","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10215","key":"10.1016\/j.canrad.2025.104767_bib0570","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"issue":"10215","key":"10.1016\/j.canrad.2025.104767_bib0575","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2025.104767_bib0580","doi-asserted-by":"crossref","first-page":"550950","DOI":"10.3389\/fonc.2020.550950","article-title":"Long-term results of partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a prospective phase II trial in China","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"issue":"10099","key":"10.1016\/j.canrad.2025.104767_bib0585","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"issue":"35","key":"10.1016\/j.canrad.2025.104767_bib0590","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2025.104767_bib0600","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.ejso.2021.06.025","article-title":"Postmastectomy radiotherapy for all node positive patients: the case against","volume":"47","author":"Dixon","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104767_bib0605","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.suronc.2017.03.003","article-title":"Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era","volume":"26","author":"Miyashita","year":"2017","journal-title":"Surg Oncol"},{"issue":"13","key":"10.1016\/j.canrad.2025.104767_bib0610","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1245\/s10434-015-4528-x","article-title":"Use of postmastectomy radiotherapy and survival rates for breast cancer patients with T1-T2 and one to three positive lymph nodes","volume":"22","author":"Huo","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2025.104767_bib0615","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3389\/fonc.2019.01551","article-title":"Post-mastectomy radiotherapy in T1-2 breast cancer patients with one to three lymph node metastases: a propensity score matching analysis","volume":"9","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib0620","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1186\/s12885-021-08423-1","article-title":"The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.canrad.2025.104767_bib0625","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10549-021-06227-2","article-title":"Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated","volume":"188","author":"Leonardi","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"10.1016\/j.canrad.2025.104767_bib0630","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1200\/JCO.2004.11.129","article-title":"Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy","volume":"22","author":"Huang","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104767_bib0635","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.breast.2021.12.013","article-title":"Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes","volume":"61","author":"Guo","year":"2022","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib0640","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1186\/s12885-021-08852-y","article-title":"POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial","volume":"21","author":"Zhao","year":"2021","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.canrad.2025.104767_bib0645","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy","volume":"337","author":"Overgaard","year":"1997","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.canrad.2025.104767_bib0650","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.canrad.2025.104767_bib0655","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1200\/JCO.2006.06.9054","volume":"24","author":"Taghian","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104767_bib0660","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2006.05.001","article-title":"Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5cm and larger","volume":"66","author":"Floyd","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104767_bib0665","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.2147\/CMAR.S309224","article-title":"Outcomes in patients with pT3N0M0 Breast cancer with and without postmastectomy radiotherapy","volume":"13","author":"Li","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"15","key":"10.1016\/j.canrad.2025.104767_bib0670","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/cncr.30675","article-title":"The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer","volume":"123","author":"Cassidy","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.canrad.2025.104767_bib0675","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ijrobp.2004.12.014","article-title":"Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation","volume":"62","author":"Jagsi","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"20","key":"10.1016\/j.canrad.2025.104767_bib0680","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1200\/JCO.19.02850","article-title":"Integration of breast reconstruction and postmastectomy radiotherapy","volume":"38","author":"Shumway","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2025.104767_bib0685","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jamaoncol.2024.2652","article-title":"Hypofractionated vs. conventionally fractionated postmastectomy radiation after implant-based reconstruction: a randomized clinical trial","volume":"10","author":"Wong","year":"2024","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104767_bib0690","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41416-024-02741-4","article-title":"A nationwide study of breast reconstruction after mastectomy in patients with breast cancer receiving postmastectomy radiotherapy: comparison of complications according to radiotherapy fractionation and reconstruction procedures","volume":"131","author":"Ryu","year":"2024","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.canrad.2025.104767_bib0695","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ijrobp.2024.07.002","article-title":"A randomized trial of hypofractionated post-mastectomy radiation therapy (PMRT) in Women with breast reconstruction (RT CHARM, Alliance A221505)","volume":"120","author":"Poppe","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104767_bib0700","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.breast.2017.06.004","article-title":"Less is more. Breast conservation might be even better than mastectomy in early breast cancer patients","volume":"35","author":"Gentilini","year":"2017","journal-title":"Breast"},{"issue":"11","key":"10.1016\/j.canrad.2025.104767_bib0705","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","article-title":"Axillary surgery in breast cancer \u2014 primary results of the INSEMA trial","volume":"392","author":"Reimer","year":"2025","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.canrad.2025.104767_bib0710","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.canrad.2025.104767_bib0715","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.canrad.2025.104767_bib0720","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"De Boniface","year":"2024","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.canrad.2025.104767_bib0725","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/annonc\/mdt151","article-title":"The standard tangential fields used for breast irradiation do not allow optimal coverage and dose distribution in axillary levels I-II and the sentinel node area","volume":"24","author":"Belkacemi","year":"2013","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2025.104767_bib0730","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1245\/s10434-022-11866-w","article-title":"Preservation of axillary lymph nodes compared with complete dissection in T1-2 breast cancer patients presenting one or two metastatic sentinel lymph nodes: the SINODAR-ONE multicenter randomized clinical trial","volume":"29","author":"Tinterri","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"15_suppl","key":"10.1016\/j.canrad.2025.104767_bib0735","doi-asserted-by":"crossref","first-page":"TPS600","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS600","article-title":"POSNOC: positive sentinel node\u2014adjuvant therapy alone versus adjuvant therapy plus clearance or axillary radiotherapy","volume":"36","author":"Goyal","year":"2018","journal-title":"J Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.canrad.2025.104767_bib0740","doi-asserted-by":"crossref","first-page":"TPS602","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS602","article-title":"Cctg MA.39 tailor RT: A randomized trial of regional radiotherapy in biomarker low-risk node-positive breast cancer (NCT03488693)","volume":"37","author":"Parulekar","year":"2019","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2025.104767_bib0745","doi-asserted-by":"crossref","first-page":"e075543","DOI":"10.1136\/bmjopen-2023-075543","article-title":"Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases \u2013 an open, multicentre, randomised non-inferiority phase 3 trial","volume":"13","author":"Alkner","year":"2023","journal-title":"BMJ Open"},{"issue":"10416","key":"10.1016\/j.canrad.2025.104767_bib0750","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(23)01082-6","article-title":"Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14\u00a0324 women in 16 trials","volume":"402","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.canrad.2025.104767_bib0755","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1200\/JCO.2015.63.6456","article-title":"DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer","volume":"34","author":"Thorsen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.canrad.2025.104767_bib0760","doi-asserted-by":"crossref","first-page":"TPS600","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS600","volume":"37","author":"Mamounas","year":"2019","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.canrad.2025.104767_bib0765","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.19.02888","article-title":"De-escalation of locoregional therapy in low-risk disease for DCIS and early-stage invasive cancer","volume":"38","author":"Hwang","year":"2020","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.canrad.2025.104767_bib0770","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J Clin Oncol"},{"issue":"10350","key":"10.1016\/j.canrad.2025.104767_bib0775","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(22)01246-6","article-title":"Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07\/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study","volume":"400","author":"Chua","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.canrad.2025.104767_bib0780","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.radonc.2013.03.026","article-title":"Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: Multicentric study of the GEC-ESTRO Breast Cancer Working Group","volume":"108","author":"Hannoun-L\u00e9vi","year":"2013","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib0785","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamaoncol.2019.4320","article-title":"Effectiveness of breast-conserving surgery and 3-dimensional conformal partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: the NRG Oncology\/RTOG 1014 phase 2 clinical trial","volume":"6","author":"Arthur","year":"2020","journal-title":"JAMA Oncol"},{"issue":"9618","key":"10.1016\/j.canrad.2025.104767_bib0790","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"371","author":"Trialists\u2019 Group","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.canrad.2025.104767_bib0795","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.canrad.2025.104767_bib0800","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"issue":"10237","key":"10.1016\/j.canrad.2025.104767_bib0805","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"issue":"28","key":"10.1016\/j.canrad.2025.104767_bib0810","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.19.02750","article-title":"Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer","volume":"38","author":"Brunt","year":"2020","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1016\/j.canrad.2025.104767_bib0815","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib0820","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2022.07.2320","article-title":"NRG RTOG 1005: a phase III trial of hypo fractionated whole breast irradiation with concurrent boost vs. conventional whole breast irradiation plus sequential boost following lumpectomy for high risk early-stage breast cancer","volume":"114","author":"Vicini","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10394","key":"10.1016\/j.canrad.2025.104767_bib0825","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/S0140-6736(23)00619-0","article-title":"Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial","volume":"401","author":"Coles","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.canrad.2025.104767_bib0830","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ijrobp.2024.07.005","article-title":"Hypofractionated whole-breast irradiation with simultaneous integrated boost for breast cancer: primary analysis of the HYPOSIB-trial (ARO 2013-05)","volume":"120","author":"Krug","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib0835","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2018.04.009","article-title":"ESTRO-ACROP guideline: interstitial multicatheter breast brachytherapy as accelerated partial breast irradiation alone or as boost \u2013 GEC-ESTRO Breast Cancer Working Group practical recommendations","volume":"128","author":"Strnad","year":"2018","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104767_bib0840","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/tbj.13764","article-title":"Outcomes of exclusive radiation therapy for older women with breast cancer according to age and comorbidity status: An observational retrospective study","volume":"26","author":"Cao","year":"2020","journal-title":"Breast J"},{"issue":"2","key":"10.1016\/j.canrad.2025.104767_bib0845","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.prro.2023.11.001","article-title":"Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline","volume":"14","author":"Shaitelman","year":"2024","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib0850","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104767_bib0855","unstructured":"Skagen Trial 1 Investigators. The Skagen Trial 1, moderately hypofractionated loco-regional adjuvant radiation therapy of early breast cancer combined with a simultaneous integrated boost: a randomised clinically controlled trial. https:\/\/clinicaltrials.gov\/study\/NCT02384733."},{"key":"10.1016\/j.canrad.2025.104767_bib0860","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1016\/j.annonc.2024.08.174","article-title":"231O Locoregional hypo- vs. normofractionated RT in early breast cancer: 5 years results of the HypoG-01 phase III Unicancer trial","volume":"35","author":"Rivera","year":"2024","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104767_bib0865","doi-asserted-by":"crossref","first-page":"576","DOI":"10.21037\/gs.2018.11.10","article-title":"Evolution of radiotherapy techniques in breast conservation treatment","volume":"7","author":"Boyages","year":"2018","journal-title":"Gland Surg"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib0870","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2015.12.027","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1","volume":"118","author":"Offersen","year":"2016","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib0875","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijrobp.2020.04.012","article-title":"Comparison of nodal target volume definition in breast cancer radiation therapy according to RTOG versus ESTRO atlases: a practical review from the TransAtlantic Radiation Oncology Network (TRONE)","volume":"107","author":"Loganadane","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib0880","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ijrobp.2008.10.034","article-title":"Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG multi-institutional and multiobserver study","volume":"73","author":"Li","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib0885","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2006.05.014","article-title":"CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning","volume":"79","author":"Kirova","year":"2006","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib0890","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","article-title":"Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer","volume":"79","author":"Feng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.canrad.2025.104767_bib0895","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2025.104767_bib0900","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2020.09.004","article-title":"Analysis of cardiac substructure dose in a large, multicentre danish breast cancer cohort (the DBCG HYPO trial): trends and predictive modelling","volume":"153","author":"Finnegan","year":"2020","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00066-018-1378-z","article-title":"Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention","volume":"195","author":"Piroth","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2025.104767_bib0910","first-page":"118","article-title":"Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial","volume":"28","author":"Thomsen","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib0915","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijrobp.2022.04.019","article-title":"Dose to the left anterior descending artery correlates with cardiac events after irradiation for breast cancer","volume":"114","author":"Zureick","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104767_bib0920","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.radonc.2021.09.006","article-title":"Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost","volume":"164","author":"Franceschini","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104767_bib0925","doi-asserted-by":"crossref","first-page":"110591","DOI":"10.1016\/j.radonc.2024.110591","article-title":"Dose constraints in breast cancer radiotherapy. A critical review","volume":"202","author":"De Rose","year":"2025","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib0930","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13014-015-0436-2","article-title":"Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy","volume":"10","author":"Skytt\u00e4","year":"2015","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104767_bib0935","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1200\/JCO.2011.34.5900","article-title":"Distribution of coronary artery stenosis after radiation for breast cancer","volume":"30","author":"Nilsson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104767_bib0940","doi-asserted-by":"crossref","first-page":"1199043","DOI":"10.3389\/fonc.2023.1199043","article-title":"Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factors","volume":"13","author":"Gueiderikh","year":"2023","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104767_bib0945","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.canrad.2025.104767_bib0950","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/0284186X.2013.765064","article-title":"Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group","volume":"52","author":"Nielsen","year":"2013","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib0955","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2017.11.022","article-title":"Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015","volume":"126","author":"Aznar","year":"2018","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.canrad.2025.104767_bib0960","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1684\/bdc.2013.1855","article-title":"Le probl\u00e8me des faibles doses en radioth\u00e9rapie\u00a0: quel risque de carcinogen\u00e8se radio-induite\u00a0?","volume":"100","author":"Chargari","year":"2013","journal-title":"Bull Cancer"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib0965","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2014.10.004","article-title":"Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients","volume":"114","author":"Grantzau","year":"2015","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2025.104767_bib0970","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/sj.bjc.6601319","article-title":"Second primary malignancies in thyroid cancer patients","volume":"89","author":"Rubino","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2025.104767_bib0975","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.radonc.2020.10.042","article-title":"Dosimetric parameters associated with radiation-induced esophagitis in breast cancer patients undergoing regional nodal irradiation","volume":"155","author":"Yaney","year":"2021","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib0980","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.meddos.2017.03.003","article-title":"Radiation-induced hypothyroidism in patients with breast cancer: a retrospective analysis of 243 cases","volume":"42","author":"Kanyilmaz","year":"2017","journal-title":"Med Dosim"},{"issue":"4","key":"10.1016\/j.canrad.2025.104767_bib0985","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.21873\/invivo.12915","article-title":"Effects of radiation dose on liver after free-breathing volumetric modulated arc therapy for breast cancer","volume":"36","author":"Park","year":"2022","journal-title":"In Vivo"},{"issue":"4","key":"10.1016\/j.canrad.2025.104767_bib0990","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ijrobp.2008.02.040","article-title":"Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study","volume":"72","author":"Stovall","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib0995","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.radonc.2013.12.002","article-title":"Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer","volume":"110","author":"Abo-Madyan","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104767_bib1000","unstructured":"A randomized phase III clinical trial evaluating post-mastectomy chestwall and regional nodal XRT and post-lumpectomy regional nodal XRT in patients with positive axillary nodes before neoadjuvant chemotherapy who convert to pathologically negative axillary nodes after neoadjuvant chemotherapy. https:\/\/clinicaltrials.gov\/study\/NCT01872975."},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib1005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13014-016-0701-z","article-title":"Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results","volume":"11","author":"De Rose","year":"2016","journal-title":"Radiat Oncol"},{"issue":"12","key":"10.1016\/j.canrad.2025.104767_bib1010","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1080\/0284186X.2021.1976828","article-title":"Pneumonitis and fibrosis after breast cancer radiotherapy: occurrence and treatment-related predictors","volume":"60","author":"Karlsen","year":"2021","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104767_bib1015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijrobp.2023.03.060","article-title":"Dose-volume predictors for radiation esophagitis in patients with breast cancer undergoing hypofractionated regional nodal radiation therapy","volume":"117","author":"Wang","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib1020","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.canrad.2025.104767_bib1025","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ijrobp.2004.08.051","article-title":"Breast radiotherapy in the lateral decubitus position: a technique to prevent lung and heart irradiation","volume":"61","author":"Campana","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib1030","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/annonc\/mdv602","article-title":"Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial","volume":"27","author":"Bourgier","year":"2016","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib1035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1470-2045(10)70013-9","article-title":"Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial","volume":"11","author":"Azria","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104767_bib1040","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S1470-2045(23)00534-X","article-title":"International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations","volume":"25","author":"Meattini","year":"2024","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104767_bib1045","doi-asserted-by":"crossref","first-page":"101384","DOI":"10.1016\/j.adro.2023.101384","article-title":"Tolerance of concurrent adjuvant radiation therapy and pembrolizumab for triple negative breast cancer: real life experience","volume":"9","author":"Tison","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2025.104767_bib1050","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/ijc.33737","article-title":"Combination of olaparib with radiotherapy for triple-negative breast cancers: one-year toxicity report of the RADIOPARP phase I trial","volume":"149","author":"Loap","year":"2021","journal-title":"Int J Cancer"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:18:06Z","timestamp":1768738686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825001830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":105,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1278321825001830"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104767","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy of breast cancer: 2025 update","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104767"}}